Identification and Characterization of a Rare Subpopulation with Cancer Stem Cell Properties in Lung Cancer
ISEF · 2015 Systems Software Second Award
Overview
Lung cancer is the leading cause of cancer-related mortality in the US, and over 70% of patients experience metastases in non-small-cell lung cancer (NSCLC). Systemic therapy treatment is often used, but there is minimal success due to recurrence. Cancer stem cells (CSCs) are known to be chemoresistant and to drive tumor movement in many cancers, and are key to addressing this issue via CSC-targeted therapy. Prior research has suggested several CSC markers in NSCLC, but some are controversial and none have had truly adequate sensitivity and specificity. Aberrant activation of the Hedgehog signaling pathway has been implicated in malignancies such as basal cell and pancreatic carcinomas, but its role in lung cancer has been poorly described. Thus, I hypothesized the role of SHh as a CSC marker. The project was conducted with both in vitro and in vivo studies, including FACS, ddPCR, IF staining, qPCR, mice treatments, MTS and migration assays. A small subpopulation of NSCLC cells was found to secrete SHh on the cell membrane, and is solely responsible for producing the SHh protein. These SHh+ cells have paracrine capabilities, demonstrating CSC features. Furthermore, they maintain CSC features in vivo, and greater SHh+ cell proportions are correlated with greater chemotherapeutic resistance. Finally, higher SHh+ percentages are linked to advanced cancer stages and shorter patient TTP, and have clinical significance as an indicator for NSCLC disease progression. These results strongly suggest the potential in creating SHh+ CSC-targeted drug therapeutics. My studies elucidate the role of Hedgehog signaling in CSC maintenance, and provide a foundation for improved chemotherapy, targeted drug treatment, and prognostic tools for lung cancer patients.
Awards (1)
- Second Award of $2,000 $2,000
Competition history
- ISEF 2015
Resources
Related projects
ISEF · 2017
High-Dimensional Single-Cell Cytometry Analysis for Understanding Cancer Stemness
ISEF · 2015
Advancing the Cancer Stem Cell Approach for Early Tumorigenesis: Delineation of p53 Pathways in Differentially Expressed Tumor-Initiating Cells
ISEF · 2021
Predicting Cancer Stem Cell Biomarkers with Machine Learning
ISEF · 2024
Identification of Lung Cancer Biomarkers Through Coding Sequences Targeted by miRNAs
ISEF · 2021
Unmasking Tumor Heterogeneity: SOX9 Regulates EMT in a Novel High-Plasticity Cell State
ISEF · 2017
Overcoming Lung Cancer with Novel Computationally Boosted Antibody Biosensor
ISEF · 2020
A Matter of Life and Breath: Early Lung Cancer Detection via Deep Learning CT Scan Analysis and DNA Methylation/exRNA Sequencing
ISEF · 2015
Characterization of A Novel Groundbreaking Radioresistance Pathway in the Endometrial Cancer Stem Cell Niche: The Interplay of WNT, Cyclooxygenase-2 (COX-2), and Hypoxia Inducible Factor-1a (HIF-1a)
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair